Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
about
Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updatePrognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospectsA joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer.The metabolomic window into hepatobiliary disease.Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse modelIntegrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.1-stearoylglycerol is associated with risk of prostate cancer: results from serum metabolomic profiling.Network features suggest new hepatocellular carcinoma treatment strategiesAlteration in circulating metabolites during and after heat stress in the conscious rat: potential biomarkers of exposure and organ-specific injuryThe effect of acyclic retinoid on the metabolomic profiles of hepatocytes and hepatocellular carcinoma cells.CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinomaHepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian CohortSynergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk OncogenesMetabolomic profiles of hepatocellular carcinoma in a European prospective cohort.Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming.Metabolic characterization of the natural progression of chronic hepatitis B.PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic studyGene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.A metabolomics investigation of non-genotoxic carcinogenicity in the rat.Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylationThe Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues.Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.Disease monitoring of hepatocellular carcinoma through metabolomics.Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.Attenuation of liver cancer development by oral glycerol supplementation in the rat.Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts.Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.MicroRNA regulation and analytical methods in cancer cell metabolism.Differential metabonomic profiles of primary hepatocellular carcinoma tumors from alcoholic liver disease, HBV-infected, and HCV-infected cirrhotic patients.A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells.
P2860
Q26741550-D02CD839-E937-4750-A3BD-FC0162FE6A51Q27003050-4037EAAE-1A3B-4DC6-AB42-2C4E147B8BDFQ27021265-DCD3B3C7-00DD-4D1B-B8E7-F3331EEDD575Q31114185-9DCFCAD2-0682-4FB9-9115-8D09B4EFF8F1Q33893457-69EE2906-D9BA-40BF-B926-26F912FE6B55Q34038257-84BF9EFA-7F44-4A84-9F31-72C5723064C1Q34214476-4E937B5A-C057-4210-A3A9-F1725622251AQ34218543-59E07D78-B6AC-4777-92BB-87C5F60A835DQ34539069-610B98E4-3E6B-49FB-90E3-D89CA96F99E2Q35012407-A4DD7AEB-5CFB-42C4-90CA-D3E0E4C46B3CQ35077773-1CFA0CA7-6CB6-4C2E-BBBD-B6245B3E4349Q35194416-9D50839E-10F8-4BF8-BE2B-B3D87103FD76Q35536490-DFF3C420-CFD3-467F-9552-EEF4C47E2C34Q35648370-3F9AB0A6-9036-4F4B-ABD7-2D5EF5E3E3F1Q35683220-69D3345C-A2C6-440F-97DD-0DB67706B7D9Q35785514-010DC78A-F59C-4EB6-ABB6-1A1FAD9AF76CQ36197829-3924F016-9219-4DEA-8688-342A3ADC80A0Q36254983-4476D751-EE7E-4F57-B531-0C778ED32A95Q36360941-04801C51-1BE2-40EA-A258-5C94AF6AC201Q36427805-42D07EDC-1D56-49F9-AF95-77BA9E3904A0Q36994664-1DAAB5C4-7453-4A37-9D1B-ABBD5B292F2CQ37031827-2552EEEE-7AFC-4081-B105-D672C0A61987Q37484601-E2950E24-A6F2-4F35-BC82-0201F0226B2DQ37565131-8FE403DB-1C2B-4A23-8136-DD013811FEBDQ37580206-08C5C7F7-CC55-48A9-80A5-DD7523157858Q37693695-A64FDC30-7D39-4A69-91DD-607C104FB89CQ37716553-0E8C8A06-FC7C-4D1E-A9C5-5E1B4956705FQ38178032-A84CC7FF-8FA0-4F56-A574-3097F4A070A4Q38235440-A9676DC8-4A1F-446A-AF3D-E2639E7AB257Q38397273-96C4AA11-AA5C-4B60-AB66-3DF28E1E301DQ38635611-DEAED711-8EB0-4C30-9CAB-802B27F98F0BQ38768256-9075307E-4152-450E-9E28-B0431A290BF8Q38883226-CFE808BB-42DC-48B4-9197-C80BE306A037Q38931947-24B43BB0-C308-417F-B79D-105CEFE45468Q38970692-F0355103-9F0E-4EE4-BDB8-3F5C7FC8DA21Q39062912-40F9A2F7-5F30-4FD9-9324-3407655791FBQ39134670-B7423425-90AE-4AF2-A401-2397DFE23E3AQ39189133-BE5C17FD-E941-452A-9796-DC40FB3DB5FBQ40053156-B75A5E22-1F12-46B9-BA92-74CD8047C008Q40175945-9791FD60-21F7-49AB-BBE5-078874C2FADA
P2860
Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tissue metabolomics of hepatoc ...... transcriptomic classification.
@en
type
label
Tissue metabolomics of hepatoc ...... transcriptomic classification.
@en
prefLabel
Tissue metabolomics of hepatoc ...... transcriptomic classification.
@en
P2093
P2860
P50
P356
P1433
P1476
Tissue metabolomics of hepatoc ...... transcriptomic classification
@en
P2093
Jean-François Dufour
Olivier Maurhofer
Paulette Bioulac-Sage
P2860
P304
P356
10.1002/HEP.26350
P407
P577
2013-05-08T00:00:00Z